You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 6,908,902

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,908,902

Title:	Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
Abstract:	Co-therapy for the treatment of neurological dysfunctions comprising administration of one or more fructopyranose sulfamates and erythropoietin.
Inventor(s):	Plata-Salaman; Carlos (Ambler, PA), Smith-Swintosky; Virginia (Hatfield, PA)
Assignee:	Ortho-McNeil Pharmaceutical, Inc. (Raritan, NJ)
Application Number:	10/056,828
Patent Claims:	1. A method for promoting neurite outgrowth in a subject, comprising administering an amount of topiramate and erythropoietin effective to promote the neurite outgrowth; wherein the amount of topiramate and the amount of erythropoietin are selected to produce a synergistic effect. 2. The method of claim 1, wherein the amount of topiramate is from about 10 to 1000 mg. 3. The method of claim 1, wherein the erythropoietin is epoetin alfa. 4. The method of claim 1, wherein the amount of erythropoietin is from about 1 to 15000 I.U./kg. 5. The method of claim 1, wherein said subject has epilepsy. 6. A pharmaceutical composition comprising topiramate, erythropoietin and a pharmaceutically acceptable carrier. 7. A process for making a pharmaceutical composition comprising mixing topiramate, erythropoietin and a pharmaceutically acceptable carrier.

Details for Patent 6,908,902

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234	06/01/1989	⤷ Try a Trial	2021-02-02
Amgen, Inc.	EPOGEN/PROCRIT	epoetin alfa	Injection	103234		⤷ Try a Trial	2021-02-02
Amgen, Inc.	PROCRIT	epoetin alfa	Injection	103234		⤷ Try a Trial	2021-02-02
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.